Relapsed Mantle Cell Lymphoma

Explore clinical trials studying Relapsed Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed Mantle Cell Lymphoma trial results

Recruiting

NCT05249959

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: ASST Spedali Civili di Brescia Brescia, Italy

S.C. Ematologia - A.S.O. "SS Antonio e Biagio e Cesare Arrigo" Alessandria, Italy

S.C. di Ematologia - A.O. S. Croce e Carle Cuneo, Italy

Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi Florence, Italy

View all 21 locations

Completed

NCT03206970

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Fujian Medical University Union Hospital Fuzhou, Fujian, China

Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

View all 13 locations

Active, Not Recruiting

NCT05471843

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Alabama At Birmingham Hospital Birmingham, Alabama, United States

Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States

Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States

Des Moines Oncology Research Association Des Moines, Iowa, United States

View all 104 locations